Biotech Values

[zipjet]

This would seem to suggest that approval is not imminent, but I suppose there is no way to predict when they will finish their review.

I would not say it that way. Clearly FDA was under a time deadline to respond to the petition. Once that time was running out they needed to reply.

So I would argue the even another week and the decision not being final on a generic Copaxone could be the basis for what they did.

There is no advantage to FDA reciting their decision until it is final.

JMHO

ij